Home ›
Trademark Categories ›
Pharmaceuticals ›
2014 ›
HE ›
HERANTIS
Trademark search for:
HERANTIS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-05-20 — Application filed
2014-07-31 — Sn assigned for sect 66a appl from ib
2014-08-01 — Application filed
2014-08-05 — Application filed
2014-09-04 — Assigned to examiner
2014-09-11 — Final disposition recorded
2014-09-12 — Office action issued
2014-09-12 — Office action issued
2014-09-12 — Office action issued
2014-10-03 — Office action issued
2015-02-12 — Office action issued
2015-02-12 — Correspondence received in law office
2015-02-13 — Teas/email correspondence entered
2015-02-14 — Approved for pub - principal register
2015-03-06 — Assigned to lie
2015-03-07 — Law office publication review completed
2015-03-25 — Notification of notice of publication e-mailed
2015-03-25 — Notice of start of opposition period created, to be sent to ib
2015-03-25 — Notification of possible opposition sent to ib
2015-04-10 — Notification processed by ib
2015-04-14 — Published for opposition
2015-04-14 — Official gazette publication confirmation e-mailed
2015-06-30 — Registered-principal register
2015-09-30 — Final disposition recorded
2015-10-29 — Final disposition recorded
2015-10-29 — Final disposition recorded
2015-11-17 — Final disposition recorded
2019-07-26 — New representative at ib received
2020-06-30 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2020-07-09 — New representative at ib received
2022-01-14 — Cancelled section 71
2022-09-14 — Total invalidation of reg ext protection created
2022-10-03 — Invalidation processed
2022-10-04 — Total invalidation of reg ext protection sent to ib
2022-10-31 — Total invalidation processed by the ib
2024-05-21 — Final status recorded
2024-07-06 — Change of name/address rec'd from ib
2024-12-06 — Death of international registration
2024-12-06 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
Herantis Pharma Plc
FI
Herantis Pharma Plc
FI-00790 Helsinki FI
Herantis Pharma Plc
FI-00790 Helsinki FI
Herantis Pharma Plc
FI-00790 Helsinki FI
Correspondent
JOHN ALUMIT ALUMIT IP 135 S JACKSON ST STE 200 GLENDALE, CA 91205 UNITED STATES
Filing Details
Filing Date:
2014-05-20
Status Date:
2024-05-21
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.